KEYNOTE-604: Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy for extensive-stage (ES) small-cell lung cancer (SCLC).


Rudin C. M. , Awad M. M. , Navarro A., Gottfried M., Peters S., Csoszi T., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.38, no.15, 2020 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 38 Issue: 15
  • Publication Date: 2020
  • Title of Journal : JOURNAL OF CLINICAL ONCOLOGY